These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 7058978)
1. Cutaneous leishmaniasis in mice: resistance to glucan immunotherapy, either alone or combined with chemotherapy. Avila JL; Biondo F; Monzón H; Convit J Am J Trop Med Hyg; 1982 Jan; 31(1):53-9. PubMed ID: 7058978 [TBL] [Abstract][Full Text] [Related]
2. Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala. Navin TR; Arana BA; Arana FE; de Mérida AM; Castillo AL; Pozuelos JL Am J Trop Med Hyg; 1990 Jan; 42(1):43-50. PubMed ID: 2405727 [TBL] [Abstract][Full Text] [Related]
3. [Experimental chemotherapy in cutaneous leishmaniasis. III. Effect of glucantime and humatin (P&D) on Leishmania garnhami and Leishmania braziliensis in hamsters]. Rezzano S; Armas JA; Moreno G; Scorza JV Acta Cient Venez; 1984; 35(5-6):394-403. PubMed ID: 6537698 [No Abstract] [Full Text] [Related]
4. Retention of antimony in hair during leishmaniasis treatment. Dorea JG; Merchan-Hamann E; Ryan DE; Holzbecher J Clin Chim Acta; 1989 Feb; 179(3):341-5. PubMed ID: 2714007 [No Abstract] [Full Text] [Related]
5. Apparent Glucantime failure in five patients with mucocutaneous leishmaniasis. Rocha RA; Sampaio RN; Guerra M; Magalhâes A; Cuba CC; Barreto AC; Marsden PD J Trop Med Hyg; 1980 Aug; 83(4):131-9. PubMed ID: 6997505 [TBL] [Abstract][Full Text] [Related]
6. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Grogl M; Thomason TN; Franke ED Am J Trop Med Hyg; 1992 Jul; 47(1):117-26. PubMed ID: 1322070 [TBL] [Abstract][Full Text] [Related]
7. Intralesional glucantime in Leishmania braziliensis braziliensis infections. Barrios LA; Costa JM; Netto EM; Vexenat CO; Cuba CC; Marsden PD Trans R Soc Trop Med Hyg; 1986; 80(1):173-4. PubMed ID: 3726989 [No Abstract] [Full Text] [Related]
8. [Experimental chemotherapy in hamsters, using paromomycin against 2 isolates of Leishmania mexicana and Leishmania braziliensis]. Rezzano S; Moreno G; Scorza JV Rev Cubana Med Trop; 1982; 34(1):34-45. PubMed ID: 6750713 [No Abstract] [Full Text] [Related]
9. Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis. Convit J; Castellanos PL; Rondon A; Pinardi ME; Ulrich M; Castes M; Bloom B; Garcia L Lancet; 1987 Feb; 1(8530):401-5. PubMed ID: 2880213 [TBL] [Abstract][Full Text] [Related]
10. Diffuse cutaneous leishmaniasis acquired in Peru. Franke ED; Lucas CM; Tovar AA; Kruger JH; De Rivera MV; Wignall FS Am J Trop Med Hyg; 1990 Sep; 43(3):260-2. PubMed ID: 2221221 [TBL] [Abstract][Full Text] [Related]
11. Antimony accumulation in hair during treatment of leishmaniasis. Dorea JG; Costa JM; Holzbecher J; Ryan DE; Marsden PD Clin Chem; 1987 Nov; 33(11):2081-2. PubMed ID: 3677383 [TBL] [Abstract][Full Text] [Related]
12. High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis. Marsden PD; Sampaio RN; Carvalho EM; Veiga JP; Costa JL; Llanos-Cuentas EA Am J Trop Med Hyg; 1985 Jul; 34(4):710-3. PubMed ID: 2992304 [TBL] [Abstract][Full Text] [Related]
13. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate. Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977 [TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime. Netto EM; Marsden PD; Llanos-Cuentas EA; Costa JM; Cuba CC; Barreto AC; Badaró R; Johnson WD; Jones TC Trans R Soc Trop Med Hyg; 1990; 84(3):367-70. PubMed ID: 2260171 [TBL] [Abstract][Full Text] [Related]
15. Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases. Costa JM; Marsden PD; Llanos-Cuentas EA; Netto EM; Carvalho EM; Barral A; Rosa AC; Cuba CC; Magalhães AV; Barreto AC J Trop Med Hyg; 1986 Dec; 89(6):319-23. PubMed ID: 3806749 [TBL] [Abstract][Full Text] [Related]
16. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis. Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365 [TBL] [Abstract][Full Text] [Related]
17. [Renal function in patients with mucocutaneous leishmaniasis treated with pentavalent antimony compounds]. Veiga JP; Rosa TT; Kimachi T; Wolff ER; Sampaio RN; Gagliardi AR; Junqueira Júnior LF; Costa JM; Marsden PD Rev Inst Med Trop Sao Paulo; 1985; 27(6):298-302. PubMed ID: 3014634 [No Abstract] [Full Text] [Related]
19. Oriental sore. A look at trends in and approaches to the treatment of leishmaniasis. Chong H Int J Dermatol; 1986 Dec; 25(10):615-23. PubMed ID: 3026976 [No Abstract] [Full Text] [Related]
20. Clinical characteristics of human Leishmania braziliensis braziliensis infections. Llanos Cuentas EA; Cuba CC; Barreto AC; Marsden PD Trans R Soc Trop Med Hyg; 1984; 78(6):845-6. PubMed ID: 6533860 [No Abstract] [Full Text] [Related] [Next] [New Search]